Latest News and Press Releases

European Biotech and consumer health company HBC has confirmed plans to extend an exclusive distribution agreement for its marine branded products with leading speciality chemicals and ingredients...

The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Havnegata 11, 6005 Ålesund, on 23 April 2021 at 13:00 CET. All shareholders are encouraged to submit a...

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act This stock exchange notice follows previous references made in the...

Today, 19 March 2021, the Board of Directors approved the Annual Report for 2020. Please find the Annual Report 2020 in Norwegian and English, including the ESG Report (Chapter 5) attached. For...

Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA (“HBC”), has today purchased 70,000 shares in HBC at an average price of NOK 9.294 per share. As a...

HBC had gross operating revenues of NOK 69.3m (67.8m) in 2020 and operating revenues of NOK 23.1m (11.1m) in the fourth quarter. Cost of Goods Sold (CoGS) amounted to NOK 16.7m (16.6m) in the quarter...

Hofseth Biocare ASA (HBC) is delighted to announce the hiring of Reto Renggli as VP within HBC’s Consumer Health Division as of February 1st 2021.The new addition to the team is the last in a series...

Reference is made to the stock exchange announcement on 21 December 2020 regarding the result of a subsequent offering (the "Subsequent Offering") in Hofseth BioCare ASA. The share capital increase...

Hofseth International AS ("HI"), has today transferred all shares from four wholly owned subsidiaries, Hofseth AS, Seafood Farmers of Norway AS, Hofseth Aalesund AS and Hofseth Logistics AS, to HI,...

RH Industri AS, a company controlled by Roger Hofseth, has today 29 December 2020 bought 60,002 shares at an average price of 8.416 per share. Roger Hofseth is CEO and primary insider in Hofseth...